摘要
目的探讨远程随访对阻塞性睡眠呼吸暂停(OSA)的患者行持续气道正压通气(CPAP)治疗依从性的影响。方法选取2018年1月~2019年5月在呼吸睡眠诊疗中心初次诊断的并接受CPAP治疗的中重度OSA患者作为研究对象,采用随机数字表分为观察组和对照组,观察组采用远程随访,对照组采用标准管理方式随访。两组患者均使用同一品牌无创呼吸机。随访内容包括:呼吸机平均使用时间、漏气量、残余呼吸暂停低通气指数(R-AHI)、平均压力值(双水平呼吸机取吸气压值)、Eporth嗜睡量表(ESS)评分及嗜睡及生活质量问卷简化版(FOSQ-10)得分,共随访6个月。结果两组患者6个月后呼吸机平均使用时间(t=-2.715,P=0.007),依从性(χ^(2)=14.874,P=0.000),差异有统计学意义;但平均压力值(t=0.520,P=0.604),漏气量(t=0.305,P=0.761),R-AHI(t=0.649,P=0.517),ESS评分(t=1.750,P=0.080)及FOSQ-10得分(t=-0.532,P=0.595),差异均无统计学意义。结论远程随访能提高OSA患者呼吸机使用的依从性。
Objective To investigate the effect of remote follow-up on continuous positive airway pressure(CPAP)adherence in patients with obstructive sleep apnea(OSA).Methods Patients with moderate to severe OSA initially diagnosed in the sleep center from January 2018 to May 2019 were selected and randomly divided into the observation group and the control group.The observation group adopted remote follow-up,while the control group used standard management methods.Both groups were treated with the same brand of device,and followed up for a total of 6 months,respectively.Their average time of usage,air leakage,residual apnea-hypopnea index(R-AHI),average pressure value(IPAP value for BiPAP device),Epworth Sleepiness Scale(ESS)and Functional Outcomes of Sleep Questionnaire(FOSQ-10)scores were included in follow-up contents.Results The average time of usage(t=-2.715,P=0.007)and adherence(χ^(2)=14.874,P=0.000)were significantly different between the two groups after 6 months,excluding amount of air leakage(t=0.305,P=0.761),R-AHI(t=0.649,P=0.517),average pressure value(t=0.520,P=0.604),ESS(t=1.750,P=0.080)and FOSQ-10 scores(t=-0.532,P=0.595).Conclusion Remote follow-up can improve adherence in patients with OSA.
作者
李亚军
赵艺璞
马利军
闫秀文
况红艳
LI Ya-jun;ZHAO Yi-pu;MA Li-jun;YAN Xiu-wen;KUANG Hong-yan(Department of Respiratory and Critical Care Medicine,Henan Provincial People′s Hospital,Zhengzhou,Henan 450003,China)
出处
《临床肺科杂志》
2021年第9期1375-1379,共5页
Journal of Clinical Pulmonary Medicine
基金
河南省科技攻关项目(No.182102311239),河南医学科技攻关计划项目(No.201601021)。
